New York Mesothelioma Lawyer Says Gene Defect Research May Improve Treatment
Attorney Joseph W. Belluck of New York’s Belluck & Fox, LLP, voices support for recently reported advances in personalized medicine.
New York, NY (PRWEB) March 24, 2012
New York mesothelioma attorney Joseph W. Belluck said today that he welcomes recent reports of the advances being made in personalized medicine.
Personalized medicine is treatment tailored to an individual’s DNA. This emerging frontier in cancer treatment could ultimately help patients with mesothelioma and other asbestos-related diseases, Belluck said.
“It’s clear that there is no one silver bullet to cure cancer,” said Belluck, a partner of Belluck & Fox, LLP, a nationally recognized New York personal injury firm that focuses on mesothelioma lawsuits.
“However, these advances in personalized medicine give us hope that many cancer patients will eventually be able to manage their disease, as diabetics do today, and live normal lives,” the attorney said.
Approximately 2,500 to 3,000 people are diagnosed each year in the U.S. with mesothelioma, according to the U.S. Centers for Disease Control and Prevention. Most victims are older workers, retired workers and veterans who were exposed to toxic asbestos in a workplace or in the military, Belluck said.
The new interest in personalized medicine results from several factors, according to a new article in the March/April edition of Technology Review. The journal is published by Massachusetts Institute of Technology.
There has been a steep drop in the cost of decoding DNA. Researchers have developed a stronger understanding of the genetics of cancer. And drug makers are focusing on developing drugs that target gene defects that cause cells to become cancerous, the article states.
Before Apple founder Steve Jobs died of pancreatic cancer last year, Jobs paid scientists more than $100,000 to decode all the DNA of his cancerous cells and normal cells in hopes of finding information to suppress his advancing cancer, according to the article. But today, the cost would be much lower.
Foundation Medicine, a biotechnology company, is now offering DNA testing of tumor tissue to identity genetic mutations and help oncologists select anti-cancer drugs that target the identified DNA defects, the article reports. Foundation Medicine expects to process about 5,000 samples this year at a cost of $5,000 a sample.
Drug companies have been utilizing the testing to get genetic explanations of why some patients respond well to their cancer drugs, but not others, the article says.
“While many of the drugs targeting specific gene defects remain in early testing, personalized medicine is an approach that holds much promise,” Belluck said.
“At Belluck & Fox, we pride ourselves on providing professional and personalized legal representation of victims of mesothelioma and asbestos-related disease. We assist each client based on their specific set of facts. These facts include their asbestos exposure and the progression of their disease. ”
About Belluck & Fox, LLP
Belluck & Fox, LLP, is a nationally recognized law firm that represents individuals with asbestos and mesothelioma claims, as well as victims of crime, motorcycle crashes, lead paint and other serious injuries. The firm provides personalized and professional representation and has won over $400 million in compensation for clients and their families.
Partner Joseph W. Belluck is AV-rated by Martindale-Hubbell and is listed in Best Lawyers in America, New York Magazine’s “Best Lawyers in the New York Area” and in Super Lawyers. Mr. Belluck has won numerous cases involving injuries from asbestos, defective medical products, tobacco and lead paint, including a recent asbestos case that settled for more than $12 million.
Partner Jordan Fox is a well-known asbestos and mesothelioma attorney who has been named to the Best Lawyers in America, New York Magazine’s “Best Lawyers in the New York Area” and to Super Lawyers. On two separate occasions his verdicts were featured as the National Law Journal’s Largest Verdict of the Year. He recently secured verdicts of $32 million and more than $19 million on behalf of individuals who had contracted mesothelioma from asbestos exposure.
In September, Belluck & Fox, LLP, won a coveted spot on a list of America’s best law firms, which was published jointly by U.S. News & World Report and Best Lawyers magazine. The listing showcased 8,782 different law firms ranked in one or more of 81 major practice areas.
For more information, contact the firm at (877) 637-6843 or through the online contact form.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebnyc-asbestos-attorney/mesothelioma-treatment/prweb9326021.htm